| |
| |
|
| Insider
Information: |
Polverino Anthony J. |
| Relationship: |
Chief Scientific Officer |
| City: |
Hackensack |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
62,367 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$330,524 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
62,367 |
|
|
| Total
Value |
$330,524 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Brainstorm Cell Therapeutics Inc |
BCLI |
Director |
2022-02-01 |
25,960 |
2018-02-01 |
0 |
Premium* |
|
|
Zymeworks Inc |
ZYME |
Chief Scientific Officer |
2022-01-07 |
36,407 |
2019-07-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BCLI |
Brainstorm Cell Therapeut... |
Director |
– • – |
2022-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,882 |
25,960 |
0 |
- |
|
| ZYME |
Zymeworks Inc |
Chief Scientific Officer |
• – – |
2022-01-07 |
4 |
A |
$13.94 |
$1,032 |
D/D |
74 |
36,407 |
0 |
- |
|
| BCLI |
Brainstorm Cell Therapeut... |
Director |
– • – |
2021-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
22,078 |
0 |
- |
|
| BCLI |
Brainstorm Cell Therapeut... |
Director |
– • – |
2021-12-10 |
4 |
A |
$0.00 |
$0 |
D/D |
4,216 |
20,078 |
0 |
- |
|
| ZYME |
Zymeworks Inc |
Chief Scientific Officer |
• – – |
2021-08-31 |
4 |
OE |
$15.00 |
$73,500 |
D/D |
4,900 |
36,333 |
0 |
- |
|
| ZYME |
Zymeworks Inc |
Chief Scientific Officer |
• – – |
2021-07-06 |
4 |
A |
$29.49 |
$13,388 |
D/D |
454 |
31,433 |
0 |
- |
|
| ZYME |
Zymeworks Inc |
Chief Scientific Officer |
• – – |
2021-03-10 |
4 |
AS |
$34.95 |
$36,631 |
D/D |
(1,048) |
30,979 |
0 |
% |
|
| ZYME |
Zymeworks Inc |
Chief Scientific Officer |
• – – |
2021-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
32,027 |
0 |
- |
|
| ZYME |
Zymeworks Inc |
Chief Scientific Officer |
• – – |
2021-01-07 |
4 |
A |
$30.92 |
$1,484 |
D/D |
48 |
29,527 |
0 |
- |
|
| ZYME |
Zymeworks Inc |
Chief Scientific Officer |
• – – |
2020-07-02 |
4 |
A |
$30.66 |
$14,962 |
D/D |
488 |
29,479 |
0 |
- |
|
| BCLI |
Brainstorm Cell Therapeut... |
Director |
– • – |
2020-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,071 |
15,862 |
0 |
- |
|
| ZYME |
Zymeworks Inc |
Chief Scientific Officer |
• – – |
2020-01-08 |
4 |
A |
$19.54 |
$7,249 |
D/D |
371 |
28,991 |
0 |
- |
|
| BCLI |
Brainstorm Cell Therapeut... |
Director |
– • – |
2019-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
12,791 |
0 |
- |
|
| ZYME |
Zymeworks Inc |
Chief Scientific Officer |
• – – |
2019-12-12 |
4 |
OE |
$15.00 |
$412,500 |
D/D |
27,500 |
28,620 |
0 |
- |
|
| ZYME |
Zymeworks Inc |
Chief Scientific Officer |
• – – |
2019-07-08 |
4 |
A |
$12.49 |
$13,989 |
D/D |
1,120 |
1,120 |
0 |
- |
|
| BCLI |
Brainstorm Cell Therapeut... |
Director |
– • – |
2019-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,501 |
10,791 |
0 |
- |
|
| BCLI |
Brainstorm Cell Therapeut... |
Director |
– • – |
2018-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
3,667 |
7,290 |
0 |
- |
|
| BCLI |
Brainstorm Cell Therapeut... |
Director |
– • – |
2018-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,623 |
3,623 |
0 |
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
